Fundz

Cyto Immune Therapeutics, Inc. reported raising $36.5 Million in an initial SEC Form D filing, from an offering of $100 Million

PRIVATEAug 06, 2021$36.5M of $100.3M raised

Amount Raised

$36.5 Million

$36.5 Million sold, per SEC Form D (first sale Aug 6, 2021)

Round Type

Venture

WilmingtonBiotechnology

Quick answer

CytoImmune Therapeutics, Inc. raised $36.5 Million in a funding round, dated August 6, 2021. CytoImmune Therapeutics, Inc. is based in Wilmington, Delaware, United States.

How much did CytoImmune Therapeutics, Inc. raise?
CytoImmune Therapeutics, Inc. raised $36.5 Million in a funding round on August 6, 2021.
What does CytoImmune Therapeutics, Inc. do?
CytoImmune Therapeutics is commercializing a coordinated immunotherapy platform for cancer treatments that combines chimeric antigen receptors (CARs) and bispecific antibodies (biAbs) with T cells and natural killer..
Where is CytoImmune Therapeutics, Inc. based and how big is it?
CytoImmune Therapeutics, Inc. is based in Wilmington, Delaware, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as CytoImmune Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Neochord raised $1M (Seed) on September 20, 2021.
  • Varda Space Industries raised $42M on September 20, 2021.
  • Allay Therapeutics raised $87M on September 20, 2021.
  • Ventyx Biosciences raised $51M on September 20, 2021.
  • Biolinq raised $62M on September 17, 2021.
  • Enkefalos Biosciences, Inc. raised $1.5M (Seed) on September 17, 2021.

Who to call at CytoImmune Therapeutics, Inc., and when

A new round usually means CytoImmune Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CytoImmune Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CytoImmune Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CytoImmune Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CytoImmune Therapeutics, Inc.

Location

1218 S 5th Ave

Wilmington, Delaware, United States

About

CytoImmune Therapeutics is commercializing a coordinated immunotherapy platform for cancer treatments that combines chimeric antigen receptors (CARs) and bispecific antibodies (biAbs) with T cells and natural killer cells. This technology reduces the patient’s time to personalized treatment and enables optimized dosing with limited off-target effects. The company is developing product candidates targeted at treating acute myeloid leukemia, glioblastoma and multiple myeloma.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CytoImmune Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for CytoImmune Therapeutics, Inc.'s next move

See what Strategic adds

CytoImmune Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.